Work

The venetoclax combined with metronomic low-dose decitabine and interferon for preventing post-transplant relapse in high-risk MDS and AML patients

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7793

Authors: Xi Yang, chenglong Li, Hong Zheng, Xiaobing Huang

Institutions: Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Pennsylvania State University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417015174

Cites:

Cited by:

Related to: